Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
-
Shares outstanding
-
266,212,950
-
Total 13F shares
-
9,789,344
-
Share change
-
+3,744,025
-
Total reported value
-
$157,564,698
-
Price per share
-
$16.10
-
Number of holders
-
44
-
Value change
-
+$59,869,890
-
Number of buys
-
36
-
Number of sells
-
8
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q2 2019
As of 30 Jun 2019,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,789,344 shares.
The largest 10 holders included
Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Polygon Management Ltd., MILLENNIUM MANAGEMENT LLC, Cormorant Asset Management, LP, Alphabet Inc., MARSHALL WACE, LLP, Artal Group S.A., Capital International Investors, and FMR LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.